Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organisation enrollees.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMID 10346415)

Published in Pharmacoeconomics on December 01, 1998

Authors

H T Hatoum1, S X Kong, C M Kania, J M Wong, W B Mendelson

Author Affiliations

1: Hind T. Hatoum & Co., Chicago, Illinois, USA.

Articles citing this

Initial evaluation of an Internet intervention to improve the sleep of cancer survivors with insomnia. Psychooncology (2011) 1.35

The association between insomnia severity and healthcare and productivity costs in a health plan sample. Sleep (2011) 1.16

Stress-related sleep disturbance and polysomnographic response to caffeine. Sleep Med (2006) 1.06

Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound Effects. Prim Care Companion J Clin Psychiatry (1999) 1.03

Assessing depression symptoms in those with insomnia: an examination of the beck depression inventory second edition (BDI-II). J Psychiatr Res (2008) 1.01

Sleep disturbance in relation to health-related quality of life in adults: the Fels Longitudinal Study. J Nutr Health Aging (2009) 1.00

Insomnia and depression. Sleep (2008) 0.99

The societal costs of insomnia. Neuropsychiatr Dis Treat (2010) 0.94

Quality of life in patients suffering from insomnia. Innov Clin Neurosci (2012) 0.93

Co-Morbidity, Mortality, Quality of Life and the Healthcare/Welfare/Social Costs of Disordered Sleep: A Rapid Review. Int J Environ Res Public Health (2016) 0.90

Quality of sleep: associations with antiretroviral nonadherence. AIDS Patient Care STDS (2011) 0.89

Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia. Sleep (2009) 0.88

A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. J Clin Sleep Med (2008) 0.88

Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month study. Sleep (2007) 0.85

Burden of chronic sleep maintenance insomnia characterized by nighttime awakenings among anxiety and depression sufferers: results of a national survey. Prim Care Companion J Clin Psychiatry (2010) 0.83

Sleep characteristics and health-related quality of life among a national sample of American young adults: assessment of possible health disparities. Qual Life Res (2013) 0.82

Insomnia and health services utilization in middle-aged and older adults: results from the Health and Retirement Study. J Gerontol A Biol Sci Med Sci (2013) 0.81

Quality of life in nonorganic and organic sleep disorders: I. Comparison with normative data. Wien Klin Wochenschr (2003) 0.80

A Collaborative Paradigm for Improving Management of Sleep Disorders in Primary Care: A Randomized Clinical Trial. Sleep (2016) 0.79

Insomnia - treatment pathways, costs and quality of life. Cost Eff Resour Alloc (2011) 0.79

Comparison of Sleep Problems in Individuals with Spinal Cord Injury and Multiple Sclerosis. J Clin Sleep Med (2016) 0.77

Quality of Sleep in an HIV Population on Antiretroviral Therapy at an Urban Tertiary Centre in Lagos, Nigeria. Neurol Res Int (2014) 0.75

Qualitative study of the quality of sleep in marginalized individuals living with HIV. Patient Prefer Adherence (2013) 0.75

Predictors of Nightly Subjective-Objective Sleep Discrepancy in Poor Sleepers over a Seven-Day Period. Brain Sci (2017) 0.75

Therapies for insomnia and comorbid chronic obstructive pulmonary disease with a focus on ramelteon (rozerem). P T (2009) 0.75

Articles by these authors

Psychophysiological insomnia: the behavioural model and a neurocognitive perspective. J Sleep Res (1997) 2.85

Sleepwalking associated with zolpidem. J Clin Psychopharmacol (1994) 1.87

Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J Biol Chem (1996) 1.85

Interorganellar communication. Altered nuclear gene expression profiles in a yeast mitochondrial dna mutant. J Biol Chem (2000) 1.80

The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability. Med Care (1999) 1.78

The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care (1999) 1.75

An overview of chronic fatigue syndrome. J Clin Psychiatry (1991) 1.65

Increased mRNA expression of a laminin-binding protein in human colon carcinoma: complete sequence of a full-length cDNA encoding the protein. Proc Natl Acad Sci U S A (1988) 1.62

Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients. Pharmacotherapy (1999) 1.42

The flower pot technique of rapid eye movement (REM) sleep deprivation. Pharmacol Biochem Behav (1975) 1.36

Hyaluronan enhances contraction of collagen by smooth muscle cells and adventitial fibroblasts: Role of CD44 and implications for constrictive remodeling. Circ Res (2001) 1.34

Rasch analysis of the Western Ontario MacMaster questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Ann Rheum Dis (1999) 1.34

Invasive amoebiasis: an emerging parasitic disease in patients infected with HIV in an area endemic for amoebic infection. AIDS (1999) 1.27

Sleep latency and duration estimates among sleep disorder patients: variability as a function of sleep disorder diagnosis, sleep history, and psychological characteristics. Sleep (2000) 1.20

Sleeping pills, insomnia and medical practice. N Engl J Med (1979) 1.20

Sleep apnea syndrome in chronic renal disease. Am J Med (1989) 1.20

The experience of insomnia and daytime and nighttime functioning. Psychiatry Res (1984) 1.19

The SF-36 Arthritis-Specific Health Index (ASHI): I. Development and cross-validation of scoring algorithms. Med Care (1999) 1.14

Prolonged sedation with propofol in the rat does not result in sleep deprivation. Anesth Analg (2001) 1.13

Antidepressant effects of light in seasonal affective disorder. Am J Psychiatry (1985) 1.13

Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom. Pharmacoepidemiol Drug Saf (2002) 1.13

Assessing the requirements for nucleotide excision repair proteins of Saccharomyces cerevisiae in an in vitro system. J Biol Chem (1996) 1.12

Endoscopic resection of gastrointestinal submucosal tumors. Hepatogastroenterology (1998) 1.10

Sleep disturbance in chronic fatigue syndrome. J Psychosom Res (1993) 1.10

Speaking, thinking, and blinking. Psychiatry Res (1981) 1.09

TATA box-binding protein (TBP) is a constituent of the polymerase I-specific transcription initiation factor TIF-IB (SL1) bound to the rRNA promoter and shows differential sensitivity to TBP-directed reagents in polymerase I, II, and III transcription factors. Mol Cell Biol (1994) 1.04

Melatonin administration in insomnia. Neuropsychopharmacology (1990) 1.03

beta-Carbolines enhance shock-induced suppression of drinking in rats. Proc Natl Acad Sci U S A (1983) 1.02

Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population. Arthritis Rheum (2000) 1.01

The SF-36 Arthritis-Specific Health Index (ASHI): II. Tests of validity in four clinical trials. Med Care (1999) 1.01

Characteristics of hepatocellular carcinoma presenting with variceal bleeding. J Gastroenterol Hepatol (1998) 1.00

Hospitalization costs associated with leiomyoma. Clin Ther (1999) 1.00

The sleep of patients with obsessive-compulsive disorder. Arch Gen Psychiatry (1982) 0.97

Flurazepam-induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes. J Nerv Ment Dis (1981) 0.97

MMPI correlates of sleep and respiratory disturbance in obstructive sleep apnea. Sleep (1999) 0.95

Evaluation of a selective screening for colorectal carcinoma: the Taiwan Multicenter Cancer Screening (TAMCAS) project. Cancer (1999) 0.95

Point mutation in intron sequence causes altered carboxyl-terminal structure in the aryl hydrocarbon receptor of the most 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant rat strain. Mol Pharmacol (1998) 0.94

Gastrointestinal symptoms and health related quality of life in patients with arthritis. J Rheumatol (2000) 0.94

Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis. Am J Manag Care (2001) 0.93

Characterization of the hypnotic properties of oleamide. Neuroreport (1999) 0.93

Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy? Lancet (1988) 0.93

Renal duplex sonography: main renal artery versus hilar analysis. J Vasc Surg (2000) 0.92

Prevalence of insomnia: a survey of the enrollees at five managed care organizations. Am J Manag Care (1998) 0.92

Sleep in fall/winter seasonal affective disorder: effects of light and changing seasons. J Psychosom Res (1994) 0.92

Disturbances of sleep and cognitive functioning in patients with dementia. Neurobiol Aging (1982) 0.92

Diazepam-stimulated increases in the synaptosomal uptake of 45Ca2+: reversal by dihydropyridine calcium channel antagonists. Eur J Pharmacol (1984) 0.92

Picrotoxinin receptor ligand blocks anti-punishment effects of alcohol. Alcohol (1989) 0.92

The regulation of insulin-induced and sleep-related human growth hormone secretion: a review. Psychoneuroendocrinology (1979) 0.91

Expression of a Mr 32,000 laminin-binding protein messenger RNA in human colon carcinoma correlates with disease progression. Cancer Res (1990) 0.91

Suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion. J Clin Invest (1975) 0.90

Cell-specific regulation of human aryl hydrocarbon receptor expression by transforming growth factor-beta(1). Mol Pharmacol (2001) 0.89

Longitudinal sleep EEG, temperature, and activity measurements across the menstrual cycle in patients with premenstrual depression and in age-matched controls. Psychiatry Res (1989) 0.89

Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment. Neuropsychobiology (2000) 0.89

Sleep related respiratory disorders in end-stage renal disease patients on peritoneal dialysis. Perit Dial Int (1992) 0.89

A prospective study of early tactile stimulation after digital nerve repair. Clin Orthop Relat Res (2001) 0.88

The effect of melatonin on normal sleep. Neuropsychopharmacology (1987) 0.87

Polydipsia, hyponatremia, and seizures in psychotic patients. J Nerv Ment Dis (1976) 0.87

Intestinal obstruction and peritonitis resulting from gastrointestinal histoplasmosis in an AIDS patient. J Formos Med Assoc (1998) 0.87

Sedative and electroencephalographic actions of erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA): relationship to inhibition of brain adenosine deaminase. Psychopharmacology (Berl) (1983) 0.87

Endoscopic diagnosis of intestinal penicilliosis marneffei: report of three cases and review of the literature. Gastrointest Endosc (1999) 0.86

Management of ischemic nephropathy: dialysis-free survival after surgical repair. J Vasc Surg (2000) 0.86

A matched comparison of MMPI responses in patients with primary snoring or obstructive sleep apnea. Sleep (1999) 0.86

Interim assessment of a community intervention to improve breast and cervical cancer screening among Korean American women. J Public Health Manag Pract (2001) 0.86

Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. J Pediatr (1984) 0.86

Graft-versus-Host disease-like syndrome in malignant thymoma. Scand J Gastroenterol (2000) 0.86

Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms. Cancer Epidemiol Biomarkers Prev (2001) 0.86

Sleep in Gilles de la Tourette syndrome. Biol Psychiatry (1980) 0.85

Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspective. Pharmacoeconomics (2001) 0.85

Sleep and circadian rhythms in affective patients isolated from external time cues. Psychiatry Res (1985) 0.85

Nifedipine blocks sleep induction by flurazepam in the rat. Sleep (1984) 0.84

A benzodiazepine receptor antagonist decreases sleep and reverses the hypnotic actions of flurazepam. Science (1983) 0.84

The vaccine efficacy of native paramyosin (Sj-97) against Chinese Schistosoma japonicum. Int J Parasitol (1998) 0.84

Economic evaluation of rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs for the treatment of osteoarthritis. Clin Ther (2001) 0.84

The hypnotic effect of propofol in the medial preoptic area of the rat. Life Sci (2001) 0.84

Seasonal affective disorder and phototherapy. Ann N Y Acad Sci (1985) 0.84

Control charts to monitor rates of adverse drug reactions. Hosp Pharm (1995) 0.84

Frequency analysis of the sleep EEG in depression. Psychiatry Res (1987) 0.84

Estimating the rate of adverse drug reactions with capture-recapture analysis. Am J Health Syst Pharm (1996) 0.84

A comparison of sleep-disordered respiration in ESRD patients receiving hemodialysis and peritoneal dialysis. Adv Perit Dial (1992) 0.83

Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database. Clin Ther (2001) 0.83

Clinical use of nafarelin in the treatment of leiomyomas. A review of the literature. J Reprod Med (2000) 0.83

A comparison of two benzodiazepine hypnotics administered with alcohol. J Clin Psychiatry (1982) 0.83

The time-dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleep. Brain Res (1977) 0.83

Acetylcholine, sleep, and depression. Hum Neurobiol (1982) 0.82

Deletion of the GABA(A) receptor beta 3 subunit eliminates the hypnotic actions of oleamide in mice. Neuroreport (2001) 0.82

Cost of prescribed NSAID-related gastrointestinal adverse events in elderly patients. Br J Clin Pharmacol (2001) 0.82

The effect of growth hormone administration on human sleep: a dose-response study. Biol Psychiatry (1980) 0.82

Differential rates of psychopathology symptoms in periodic limb movement disorder, obstructive sleep apnea, psychophysiological insomnia, and insomnia with psychiatric disorder. Sleep (1999) 0.82

Binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to AH receptor in placentas from normal versus abnormal pregnancy outcomes. Chemosphere (1997) 0.81

Sleep during chronic ethanol administration and withdrawal in rats. J Stud Alcohol (1978) 0.81

TATA elements direct bi-directional transcription by RNA polymerases II and III. Nucleic Acids Res (1996) 0.81

Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis. Int J Clin Pract (2013) 0.81

A psychophysiological study of insomnia. Psychiatry Res (1986) 0.81

Colonoscopic manifestations of primary colorectal lymphoma. Endoscopy (2001) 0.81

Reduction of REM sleep by a tryptophan-free amino acid diet. Life Sci (1979) 0.81

Differential diagnosis of psychiatric disturbance in pre-school children. Br J Psychiatry (1972) 0.81

Buspirone administration to sleep apnea patients. J Clin Psychopharmacol (1991) 0.80